Nationally recognized public health leader and former Director of the CDC to provide strategic guidance on GX-03 development, the Company’s lead investigational therapy LOS ANGELES, February 17, 2026- ...

Nationally recognized public health leader and former Director of the CDC to provide strategic guidance on GX-03 development, the Company’s lead investigational therapy Turn Therapeutics, Inc. (Nasdaq ...

Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatologic conditions, today announced the appointment of ...

Pacers, Hoosiers and Super Bowl. JMV joins to discuss. Today’s Popcorn Moment: Fmr. CDC Director Dr. Robert Redfield Now Says the COVID Jab Should Not Have Been Called a Vaccine Today on the ...

Is Alzheimer’s disease a public health crisis yet? Now? Certainly yes for far too many families, but if not today for society in general, the wait will be brief. The Chicago Tribune carried an opinion ...

Today, the generation that survived that crisis is aging into the next public health emergency. Alzheimer’s disease affects more than 7 million Americans, and cases are expected to nearly double ...

Turn Therapeutics is a biotechnology company developing and commercializing products for dermatology, wound care, and infectious disease. The Company has received three FDA clearances for its ...

LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, ...